Back to Agenda
SESSION 2: GETTING IT RIGHT: SYSTEMATIC COLLECTION OF IMPACT RELEVANT DATA THROUGHOUT THE PRODUCT LIFE-CYCLE
Session Chair(s)
Vicki Edwards, RPh
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
June Raine, MD, MSc, FRCP
Chief Executive
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
This session looks at the generation of impact relevant data as a systematic process considering the need for, the nature of and the approach to data collection throughout a product’s life-cycle.
Speaker(s)
Framework for utilising data to support decision making - Industry experience
Emma Du Four, MBA
-, United Kingdom
Regulatory and R&D Policy Professional
How could novel technologies and access to real world data facilitate impact research?
Alison Cave, PhD
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Safety Officer
Patients' involvement in generating impact relevant data
Kaisa Immonen
European Patients' Forum, Belgium
Director of Policy
Have an account?